Mivobulin
Alternative Names: CI 980; Mivobulin isethionate; NSC 370147; NSC 613862; NSC 635370; PD 13114154Latest Information Update: 20 Jul 2011
Price :
$50 *
At a glance
- Originator Southern Research Institute
- Class Antineoplastics
- Mechanism of Action Tubulin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias; Glioma; Malignant melanoma; Ovarian cancer; Prostate cancer; Small cell lung cancer; Solid tumours
Most Recent Events
- 20 Jul 2011 Discontinued - Phase-II for Glioma in USA (IV)
- 20 Jul 2011 Discontinued - Phase-II for Malignant melanoma in USA (IV)
- 20 Jul 2011 Discontinued - Phase-II for Ovarian cancer in USA (IV)